Fourteen babies died and GlaxoSmithKline gets fined what amounts to $6643 a head? How can this happen? Actually, these kinds of unethical trials happen all...
Marc Dunoyer, Global Head of GSK Rare Diseases, explains why rare diseases present unique opportunities for pharmaceutical companies and his one wish for a more...
Announcing GSK's Q4 and full year results, CEO Sir Andrew Witty outlines the company's progress during 2011. 0:00 Performance and outlook 2:23 Returns to shareholders...
www.StockMarketFunding.com Human Genome's 'Blockbuster' Drug Benlystal Potential Undervalued in Bid by GSK vs HGSI BREAKING NEWS! Human Genome Rejects $2.6B Bid From GlaxoSmithKline (Update 1)....
London 2012 provider, GSK, unveils sign celebrating its scientific contribution to the Games. The sign, which is 41m wide, sits on the side of GSK's...